Levodopa (administration & dosage) < Levodopa (adverse effects) < Levodopa (analogs & derivatives)

Facettes :

List of bibliographic references indexed by Levodopa (adverse effects)

Number of relevant bibliographic references: 111.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000398 (2016)	Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau	D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia
000407 (2016)	A Jon Stoessl [Canada]	Comment: Increased D3 binding-A substrate for levodopa-induced dyskinesias?
000424 (2016)	Marc Morissette [Canada] ; Nicolas Morin [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]	Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
000585 (2015)	Michele Tinazzi ; Alfonso Fasano ; Christian Geroin ; Francesca Morgante ; Roberto Ceravolo ; Simone Rossi ; Astrid Thomas ; Giovanni Fabbrini ; Annarita Bentivoglio ; Filippo Tamma ; Giovanni Cossu ; Nicola Modugno ; Mario Zappia ; Maria Antonietta Volontè ; Carlo Dallocchio ; Giovanni Abbruzzese ; Claudio Pacchetti ; Roberto Marconi ; Giovanni Defazio ; Margherita Canesi ; Antonino Cannas ; Antonio Pisani ; Rina Mirandola ; Paolo Barone ; Carmine Vitale	Pisa syndrome in Parkinson disease: An observational multicenter Italian study.
000592 (2015)	Matthieu F. Bastide [France] ; Wassilios G. Meissner [France] ; Barbara Picconi [Italie] ; Stefania Fasano [Italie] ; Pierre-Olivier Fernagut [France] ; Michael Feyder [Suède] ; Veronica Francardo [Suède] ; Cristina Alcacer [Suède] ; Yunmin Ding [États-Unis] ; Riccardo Brambilla [Italie] ; Gilberto Fisone [Suède] ; A. Jon Stoessl [Canada] ; Mathieu Bourdenx [France] ; Michel Engeln [France] ; Sylvia Navailles [France] ; Philippe De Deurwaerdère [France] ; Wai Kin D. Ko [France] ; Nicola Simola [Italie] ; Micaela Morelli [Italie] ; Laurent Groc [France] ; Maria-Cruz Rodriguez [Espagne] ; Eugenia V. Gurevich [États-Unis] ; Maryka Quik [États-Unis] ; Michele Morari [Italie] ; Manuela Mellone [Italie] ; Fabrizio Gardoni [Italie] ; Elisabetta Tronci [Italie] ; Dominique Guehl [France] ; François Tison [France] ; Alan R. Crossman [Royaume-Uni] ; Un Jung Kang [Suède] ; Kathy Steece-Collier [États-Unis] ; Susan Fox [Canada] ; Manolo Carta [Italie] ; M. Angela Cenci [Suède] ; Erwan Bézard [Royaume-Uni]	Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
000630 (2015)	Umar A. Shuaib ; Ali H. Rajput ; Christopher A. Robinson ; Alex Rajput	Neuroleptic‐induced Parkinsonism: Clinicopathological study
000674 (2015)	Anthony E. Lang ; Ramon L. Rodriguez ; James T. Boyd ; Sylvain Chouinard ; Cindy Zadikoff ; Alberto J. Espay ; John T. Slevin ; Hubert H. Fernandez ; Mark F. Lew ; David A. Stein ; Per Odin ; Victor S. C. Fung ; Fabian Klostermann ; Alfonso Fasano ; Peter V. Draganov ; Nathan Schmulewitz ; Weining Z. Robieson ; Susan Eaton ; Krai Chatamra ; Janet A. Benesh ; Jordan Dubow	Integrated safety of levodopa‐carbidopa intestinal gel from prospective clinical trials
000794 (2015)	Camila Catherine Aquino [Canada] ; Susan H. Fox	Clinical spectrum of levodopa-induced complications.
000801 (2015)	Vincent A. Jourdain ; Nicolas Morin ; Laurent Grégoire ; Marc Morissette ; Thérèse Di Paolo	Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
000812 (2015)	Isabelle Beaulieu-Boire [Canada] ; Anthony E. Lang	Behavioral effects of levodopa.
000871 (2014)	Olivier Rascol [France] ; Susan Fox [Canada] ; Fabrizio Gasparini [Suisse] ; Christopher Kenney [États-Unis] ; Thérèse Di Paolo [Canada] ; Baltazar Gomez-Mancilla [Canada]	Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias.
000877 (2014)	Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]	UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
000882 (2014)	Robert A. Hauser [États-Unis] ; C Warren Olanow [États-Unis] ; Karl D. Kieburtz [États-Unis] ; Emmanuelle Pourcher [Canada] ; Any Docu-Axelerad [Roumanie] ; Mark Lew [États-Unis] ; Olexandr Kozyolkin [Ukraine] ; Ann Neale [États-Unis] ; Chris Resburg [États-Unis] ; Uwe Meya [États-Unis] ; Christopher Kenney [États-Unis] ; Stephen Bandak [États-Unis]	Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.
000933 (2014)	Sherri L. Thiele [Canada] ; Betty Chen [Canada] ; Charlotte Lo [Canada] ; Tracey S. Gertler [États-Unis] ; Ruth Warre [Canada] ; James D. Surmeier [États-Unis] ; Jonathan M. Brotchie [Canada] ; Joanne E. Nash [Canada]	Selective loss of bi-directional synaptic plasticity in the direct and indirect striatal output pathways accompanies generation of parkinsonism and l-DOPA induced dyskinesia in mouse models
000951 (2014)	Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Robert A. Hauser [États-Unis] ; Stanley Fahn [États-Unis] ; Joseph Jankovic [États-Unis] ; Emmanuelle Pourcher [Canada] ; Ann Hsu [États-Unis] ; Martin O'Connell [États-Unis] ; Sherron Kell [États-Unis] ; Suneel Gupta [États-Unis]	Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
000A17 (2014)	I A Prescott [Canada] ; L D Liu [Canada] ; J O Dostrovsky [Canada] ; M. Hodaie [Canada] ; A M Lozano [Canada] ; W D Hutchison [Canada]	Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.
000A29 (2014)	Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada]	Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
000A70 (2014)	Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. Fox	Emerging drugs for levodopa-induced dyskinesia.
000B40 (2014)	Shraddha Sapkota [Canada] ; Myrlene Gee ; Jennifer Sabino ; Derek Emery ; Richard Camicioli	Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
000B60 (2014)	Thérèse Di Paolo [Canada] ; Laurent Grégoire [Canada] ; Dominik Feuerbach [Canada] ; Walid Elbast [Canada] ; Markus Weiss [Canada] ; Baltazar Gomez-Mancilla [Canada]	AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys.
000B77 (2014)	Susan H. Fox [Canada] ; Anthony E. Lang [Canada]	'Don't delay, start today': delaying levodopa does not delay motor complications.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Levodopa (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Levodopa (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Levodopa (adverse effects)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022